Free Trial

Trading of Bio-Rad Laboratories was halted at 09:42 AM EST due to "LULD pause".

NYSE:BIO.B

Bio-Rad Laboratories (BIO.B) Stock Price, News & Analysis

Bio-Rad Laboratories logo
$247.05 0.00 (0.00%)
As of 08/1/2025

About Bio-Rad Laboratories Stock (NYSE:BIO.B)

Key Stats

Today's Range
$247.05
$247.05
50-Day Range
$223.15
$264.52
52-Week Range
$225.29
$359.22
Volume
72 shs
Average Volume
47 shs
Market Capitalization
$6.72 billion
P/E Ratio
21.06
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive BIO.B Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Bio-Rad Laboratories and its competitors with MarketBeat's FREE daily newsletter.

BIO.B Stock News Headlines

Market Crash Warning: How to Protect Your Wealth Before August 12th
New China tariffs hit August 12th—and Wall Street’s already moving. Banks and billionaires are quietly shifting out of stocks, while everyday investors remain exposed. A free guide reveals where the smart money is going—and how to protect your wealth before the next sell-off.
Bio-Rad Labs B (BIOb) Earnings Dates & Reports
Bio-Rad price target lowered to $409 from $430 at RBC Capital
See More Headlines

BIO.B Stock Analysis - Frequently Asked Questions

Bio-Rad Laboratories' stock was trading at $325.60 at the start of the year. Since then, BIO.B shares have decreased by 24.1% and is now trading at $247.05.

Bio-Rad Laboratories, Inc. (NYSE:BIO.B) issued its quarterly earnings results on Thursday, July, 31st. The company reported $2.61 EPS for the quarter. Bio-Rad Laboratories had a net margin of 12.50% and a trailing twelve-month return on equity of 4.01%.

Bio-Rad Laboratories subsidiaries include these companies: Celsee, Raindance Technologies Limited, GnuBIO Inc., Bio-Rad AbD Serotec GmbH, QuantaLife, DiaMed Holding AG, Blackhawk Biosystems, and others.

Shares of BIO.B stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Last Earnings
7/31/2025
Today
8/05/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Measuring And Control Equipment
Current Symbol
NYSE:BIO.B
CIK
12208
Employees
8,200
Year Founded
1952

Profitability

EPS (Trailing Twelve Months)
$11.73
Trailing P/E Ratio
21.06
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$1.84 billion
Net Margins
12.50%
Pretax Margin
17.62%
Return on Equity
4.01%
Return on Assets
2.82%

Debt

Debt-to-Equity Ratio
0.17
Current Ratio
5.12
Quick Ratio
3.67

Sales & Book Value

Annual Sales
$2.57 billion
Price / Sales
2.62
Cash Flow
$10.39 per share
Price / Cash Flow
23.77
Book Value
$234.52 per share
Price / Book
1.05

Miscellaneous

Outstanding Shares
27,210,000
Free Float
19,490,000
Market Cap
$6.72 billion
Optionable
Not Optionable
Beta
0.76

Social Links

These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

This page (NYSE:BIO.B) was last updated on 8/5/2025 by MarketBeat.com Staff
From Our Partners